Unknown

Dataset Information

0

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.

ABSTRACT:

SUBMITTER: Muhsen K 

PROVIDER: S-EPMC8757568 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
| S-EPMC8461568 | biostudies-literature
Unknown BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
| S-EPMC8728797 | biostudies-literature
Unknown Short term safety of booster immunization with BNT162b2 mRNA COVID-19 vaccine in healthcare workers
| S-EPMC8755369 | biostudies-literature
Unknown Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
| S-EPMC8531987 | biostudies-literature
Unknown Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
| S-EPMC8675294 | biostudies-literature
Unknown Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France.
| S-EPMC8457759 | biostudies-literature
Unknown Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities.
| S-EPMC8710399 | biostudies-literature
Unknown Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose.
| S-EPMC9239876 | biostudies-literature
Unknown Optimizing COVID-19 surveillance in long-term care facilities: a modelling study.
| S-EPMC7721547 | biostudies-literature
Unknown Immunogenicity of a BNT162b2 vaccine booster in health-care workers.
| S-EPMC8504922 | biostudies-literature